Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Cornetta

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Biomedicines|May 27, 2017
<i>Biomedicines</i>-Moving Biologic Agents into Approved Treatment OptionsKenneth Cornetta
Blood Cells, Molecules & Diseases|July 10, 2003
Regulatory issues in human gene therapyKenneth Cornetta
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2010
Flexibility in cell targeting by pseudotyping lentiviral vectorsDaniela Bischof, Kenneth Cornetta
Methods in Enzymology|February 28, 2012
Developing novel lentiviral vectors into clinical productsAnna Leath, Kenneth Cornetta
Methods in Molecular Biology (Clifton, N.J.)|December 27, 2008
Detection of replication competent retrovirus and lentivirusLakshmi Sastry, Kenneth Cornetta
Biomedicines|May 27, 2017
Design and Potential of Non-Integrating Lentiviral VectorsAaron Shaw, Kenneth Cornetta
Human Gene Therapy|July 23, 2002
Regulatory issues for clinical gene therapy trialsKenneth Cornetta, Franklin O Smith
Academic Medicine : Journal of the Association of American Medical Colleges|January 26, 2013
Balancing personalized medicine and personalized careKenneth Cornetta, Candy Gunther Brown
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2008
Production of retroviral vectors for clinical useKenneth Cornetta, Lilith Reeves, Scott Cross
CSH Protocols|March 2, 2011
Transduction of primary hematopoietic cells by retroviral vectorsKenneth Cornetta, Karen E Pollok, A Dusty Miller
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Biomedicines|May 27, 2017
<i>Biomedicines</i>-Moving Biologic Agents into Approved Treatment OptionsKenneth Cornetta
Blood Cells, Molecules & Diseases|July 10, 2003
Regulatory issues in human gene therapyKenneth Cornetta
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2010
Flexibility in cell targeting by pseudotyping lentiviral vectorsDaniela Bischof, Kenneth Cornetta
Methods in Enzymology|February 28, 2012
Developing novel lentiviral vectors into clinical productsAnna Leath, Kenneth Cornetta
Methods in Molecular Biology (Clifton, N.J.)|December 27, 2008
Detection of replication competent retrovirus and lentivirusLakshmi Sastry, Kenneth Cornetta
Biomedicines|May 27, 2017
Design and Potential of Non-Integrating Lentiviral VectorsAaron Shaw, Kenneth Cornetta
Human Gene Therapy|July 23, 2002
Regulatory issues for clinical gene therapy trialsKenneth Cornetta, Franklin O Smith
Academic Medicine : Journal of the Association of American Medical Colleges|January 26, 2013
Balancing personalized medicine and personalized careKenneth Cornetta, Candy Gunther Brown
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2008
Production of retroviral vectors for clinical useKenneth Cornetta, Lilith Reeves, Scott Cross
CSH Protocols|March 2, 2011
Transduction of primary hematopoietic cells by retroviral vectorsKenneth Cornetta, Karen E Pollok, A Dusty Miller
Pageof 9